Do We Get Samples of the Report?

Yes, you will receive a sample copy of the market research report from the sales team when you put a query to us. The sample report is free and offers a brief view of the report and information on data available before you purchase the full-fledged report. Also, we will provide a demo sample for any oncoming study.

How to Buy a Market Report?

Select the report you wish to purchase and proceed to buy it by making an online payment. We use a secured gateway for payment transfers and do not share your financial information with any unconcerned third party.

In Which Format Will I Get the Report?

The report will be delivered in spreadsheet and PDF format. In some cases, PPT formats could be available as well.

In How Much Time I will Get the Report After Purchase?

After confirmation of the payment, you will receive the electronic format of the report at your registered email address in (mention the timeline for the delivery). If you buy a report over a holiday or weekend, we will process the request the next working day.

How Can I Get the Report Customized?

Market studies and reports already contain important data and are ready for distribution to the purchaser. However, if there is any particular query, addition, or customization you require, then contact us on our email id or phone. We will look to accommodate your request and see what can be done at the earliest. The research team will design the report accordingly and discuss the solutions beforehand with you.

How Much Will It Cost to Get a Report Customized?

The price of the customized report will be conveyed to you by our team after we agree on the deliverable. A delivery timeline will be set so that you get the report within the expected date. Any requests for customizations after selling the report will be handled by a separate department and the prices for the same mentioned upfront.

Can I Buy Only a Particular Segment of the Study?

While usually such a request is not accommodated as any market research report is wholesome and the cost of the report is for overall contents, in special cases, we may be able to sell select segments of the report based on your requirements.

Is There Any Available Discount?

Our team will love to support academicians, start-ups, students, and others with consulting and research. Thus, our pricing plan is based on keeping these interests in mind and is already affordable. However, we may have discounts available for particular customer types and reports. So, contact us for more information.

Which Services Are Complimentary Before Purchasing the Report?

We have consumer-centric reports and offer several facilities before selling. You will get a free review and sample report, talk to our customer care team for any additions to be done and meet special requirements, and interact with our analysts for deeper understanding.

Will I Receive a Bill or Invoice for the Report Purchased?

Yes, you will get an invoice for the purchase you made. The invoice will be sent to you electronically on your registered email id.

What If I am Unable to Find the Report in the Catalog?

We have a vast database of market reports and studies and there are a few which may not have been uploaded yet. If you are unable to find the one you want, then get in touch with our sales team by phone or email and we will connect with you for assistance.

How Often Are the Existing Studies Updated?

Not every study is the same. Thus, the update for reports will depend on the ongoing research and changes if any to be incorporated in the document or not.

What If the Report Does Not Contain the Information I Want?

The market research reports are constructed keeping in mind the industry trends, nature of the study, and required inputs. But if you want something more than what is stated in the report, we can help you out with further research if possible. Contact us right away, and we will do the needful to aid you.

Is the Payment Refundable?

Once the payment is done, it is non-refundable because as per the standard policy, the utility of the reports is based on knowledge sharing, and thus, a refund is not possible to make after we have issued you obtain the study. To avoid the hassle, we have a detailed view of the report and its ideas through a sample report.

What If the Payment Fails?

If the payment fails then be assured that you shall receive the money back to the source payment mode from the payment gateway. Aarkstore is not responsible for any loss of payment in the process.

Can I Avail the Report of a Particular Country/Region?

Yes, we can provide a report or segment related to a particular region or geography if we have that feature available for the document.

Do You Offer Support After Purchase?

Yes, we are here to solve any queries you may have for the report from our analyst till a given timeframe. To understand more about this, get in touch with us.

Global Psoriatic Arthritis Market 2023

DESCRIPTION

TABLE OF CONTENTS

RELATED REPORTS

SAMPLE REQUEST

REVIEWS

DESCRIPTION

The global market for psoriatic arthritis treatment is projected to reach USD 12.72 billion by 2029, growing at a CAGR of 6.1% from USD 8.27 billion in 2022. Psoriatic arthritis is a chronic inflammatory rheumatic disease that affects up to 30% of psoriasis patients aged 30 to 60. It is more common in women. The exact cause is unknown, but family history and certain risk factors play a role. Diagnosis involves imaging techniques and symptom evaluation. Treatment options include non-steroidal anti-inflammatory drugs, disease-modifying anti-rheumatic drugs, biologics, and emerging therapies. The market is driven by the introduction of new drugs and the demand for improved treatments. IL inhibitors and oral JAK inhibitors show promise. The market has over 25 assets in development, with many in Phase III trials. The introduction of novel therapies will fuel market growth. Targeting inflammatory pathways beyond TNF, such as IL-23/IL-17, has proven effective. Technological advancements are expected to enhance interventions and outcomes in the future.

The report covers market size and growth, segmentation, competitive landscape, trends and strategies for global psoriatic arthritis market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors approaches.

Market Segmentation
The market is segmented based on various factors, including drug class, disease type, gender type, age group, severity type, and geography.
Drug class: interleukin inhibitors, NSAIDs, TNF inhibitors, others
Disease type: spondylitis, dactylitis, enthesitis
Gender: men, women
Age group: 50 years and below, 50 years and above
Severity type: moderate, mild, severe

Segmentation by Geography
North America US
Europe Germany, France, UK, Italy, Spain
APAC - China, Japan

TNF-Alpha inhibitors dominate the global psoriatic arthritis treatment market but the fastest growth is expected in interleukin inhibitors. Approvals of drugs like Skyrizi and Cosentyx will drive the market. Women make up a significant portion of the market due to increased risk. Enthesitis holds a significant share but Dactylitis will grow the fastest. Individuals below 50 will make up a substantial portion. Mild form is significant but moderate form will grow the fastest. The United States dominates the market due to affordability, knowledge, and technology. Germany will experience rapid growth due to healthcare access and awareness. Biosimilars in China and Japan will bring changes. China has the highest number of cases, followed by Spain and the U.K. PsA prevalence is increasing in the European Union.

Competitive Landscape
Major players in the global psoriatic arthritis treatment market include AbbVie Inc, Johnson & Johnson, Takeda Pharmaceutical Company Limited, Biogen Inc, UCB SA, Amgen Inc., Bristol-Myers Squibb Company, Pfizer Inc., Eli Lilly and Company, and Novartis AG. These companies are employing strategies such as collaborations, acquisitions, geographic expansion, research and development, and manufacturing novel drugs to strengthen their product portfolios and compete in the market. Other notable players include Bausch Health Companies Inc., Biocad Biopharmaceutical Co., Bio-Thera Solutions, Ltd., Eli Lilly and Company, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Meiji Holdings Co., Ltd., Sun Pharmaceuticals Industries Limited, among others. These players prioritize research and development to develop advanced psoriatic drugs and maintain their industry position.

Scope of the Report
To analyze and forecast the market size of the global psoriatic arthritis market.
To classify and forecast the global psoriatic arthritis market based on drug class, disease type, gender, age group, severity type, geography.
To identify drivers and challenges for the global psoriatic arthritis market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global psoriatic arthritis market.
To identify and analyze the profile of leading players operating in the global psoriatic arthritis market.

Why Choose This Report
Gain a reliable outlook of the global psoriatic arthritis market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.

Companies Mentioned
AbbVie Inc, Amgen Inc., Bausch Health Companies Inc., Biocad Biopharmaceutical Co., Biogen Inc, Bio-Thera Solutions Ltd., Bristol-Myers Squibb Company, Eli Lilly and Company, Jiangsu Hengrui Pharmaceuticals Co. Ltd., Johnson & Johnson, Meiji Holdings Co. Ltd., Novartis AG, Pfizer Inc., Sun Pharmaceuticals Industries Limited, Takeda Pharmaceutical Company Limited, UCB SA

TABLE OF CONTENTS

PART 1. INTRODUCTION
1.1 Description
1.2 Objectives of The Study
1.3 Market Segment
1.4 Years Considered for The Report
1.5 Currency
1.6 Key Target Audience
PART 2. RESEARCH METHODOLOGY
2.1 Primary Research
2.2 Secondary Research
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
4.1 Introduction
4.2 Drivers
4.3 Restraints
PART 5. GLOBAL PSORIATIC ARTHRITIS MARKET BY DRUG CLASS
5.1 Interleukin inhibitors
5.2 NSAIDs
5.3 TNF inhibitors
5.4 Others
PART 6. GLOBAL PSORIATIC ARTHRITIS MARKET BY DISEASE TYPE
6.1 Spondylitis
6.2 Dactylitis
6.3 Enthesitis
PART 7. GLOBAL PSORIATIC ARTHRITIS MARKET BY GENDER
7.1 Men
7.2 Women
PART 8. GLOBAL PSORIATIC ARTHRITIS MARKET BY AGE GROUP
8.1 50 years and below
8.2 50 years and above
PART 9. GLOBAL PSORIATIC ARTHRITIS MARKET BY SEVERITY TYPE
9.1 Moderate
9.2 Mild
9.3 Severe
PART 10. GLOBAL PSORIATIC ARTHRITIS MARKET BY GEOGRAPHY
10.1 North America
10.2 Europe
10.3 APAC
PART 11. COMPANY PROFILES
11.1 AbbVie Inc
11.2 Amgen Inc.
11.3 Bausch Health Companies Inc.
11.4 Biocad Biopharmaceutical Co.
11.5 Biogen Inc
11.6 Bio-Thera Solutions, Ltd.
11.7 Bristol-Myers Squibb Company
11.8 Eli Lilly and Company
11.9 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
11.10 Johnson & Johnson
11.11 Meiji Holdings Co., Ltd.
11.12 Novartis AG
11.13 Pfizer Inc.
11.14 Sun Pharmaceuticals Industries Limited
11.15 Takeda Pharmaceutical Company Limited
11.16 UCB SA
DISCLAIMER

RELATED REPORTS

SAMPLE REQUEST

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

REVIEWS

There is no Reviews available

Search and Get the Latest Market Research Reports

Global Psoriatic Arthritis Market 2023

Global Hematology Flow Cytometry Database

Global Hematology Market Shares Competitive Analysis

Psoriatic Arthritis (Musculoskeletal) - Drugs in Development, 2021

Global Psoriatic Arthritis Therapeutics Market Research Report 2021-2025

FAQs